The effect of aromatherapy with peppermint essential oil on symptoms of premenstrual syndrome

Phase 3

Conditions: N94.3
Premenstrual tension syndrome
Premenstrual Syndrome.

Registration Number: IRCT20221206056724N1

Lead Sponsor: Gonabad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 80

Inclusion Criteria

Willingness to participate in the study
No smoking and drugs
Absence of medical diseases and disorders related to the reproductive system based on the person's statements
Not suffering from psychiatric diseases, anxiety disorders, depression and stress based on the person's statements and scores from the questionnaire.
Menstrual cycles of 21-35 days with a duration of 4-8 days
Having moderate or severe premenstrual syndrome based on the PSST questionnaire
Failure to use drugs or supplements effective on premenstrual syndrome from 3 months before the start of the study
Not doing sports professionally
No stressful event in the last 6 months
Not suffering from respiratory diseases and disorders in the olfactory system based on the person's statements
Insensitivity to the peppermint based on the individual's statements

Exclusion Criteria

Unwillingness to continue cooperation
Changes in the intervals of menstrual cycles (less than 21 days and more than 35 days) and the number of menstrual days (less than 4 days and more than 8 days)
Taking drugs, supplements or using other effective alternative medicine methods on premenstrual syndrome
Allergy to peppermint essential oil used in the study
Use less than 5 days before menstruation and less than 2 days after the start of menstruation or less than 2 times a day
Failure to complete or incomplete completion of questionnaires in each of the follow-up stages

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms of premenstrual syndrome. Timepoint: Before the start of the intervention and during the intervention in two menstrual cycles. Method of measurement: Questionnaire for screening of premenstrual syndrome symptoms.

Secondary Outcome Measures